Protein levels measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with Vemurafenib in combination with chromatin-targeting compounds (immunofluorescence dataset 3 of 4) - Dataset (ID:20276)
- Detail
- Small Molecules Studied
- Cell Lines Studied
- Proteins Studied
- Antibodies Studied
- Data Columns
- Results
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10068-1 | Vemurafenib | PLX4032; RG7204; R7204; RO5185426 | LSM-1068 |  | 42611257 |
| 10144-2 | Olaparib | AZD2281; KU-0059436 | LSM-1145 |  | 23725625 |
| 10145-1 | Veliparib | ABT-888 | LSM-1146 |  | 11960529 |
| 10282-2 | Vorinostat | suberoylanilide hydroxamic acid (SAHA); Zolinza | LSM-3828 |  | 5311 |
| 10300-1 | Azacitidine | 5-azacytidine; Vidaza; AZA | LSM-5218 |  | 9444 |
| 10301-1 | Decitabine | 5-aza-2'-deoxycytidine; Dacogen; DAC | LSM-5855 |  | 451668 |
| 10302-1 | RG-108 | LSM-6283 |  | 702558 | |
| 10303-1 | Iniparib | BSI 201 | LSM-6317 |  | 9796068 |
| 10304-1 | Rucaparib | AG014699; PF-01367338 | LSM-4947 |  | 9931954 |
| 10305-1 | JW55 | LSM-6318 |  | 2946601 | |
| 10306-1 | C646 | LSM-43281 |  | 2871948 | |
| 10307-1 | Garcinol | LSM-6319 |  | ||
| 10308-1 | Anacardic acid | LSM-6320 |  | 167551 | |
| 10309-1 | CTB | LSM-6321 |  | 729859 | |
| 10310-1 | Belinostat | PXD101 | LSM-43181 |  | 53437714 |
| 10311-1 | Entinostat | MS-275; MS-27-275 | LSM-4811 |  | 4261 |
| 10312-1 | Mocetinostat | MGCD0103 | LSM-5344 |  | 9865515 |
| 10313-1 | Pracinostat | SB939 | LSM-43290 |  | 56603532 |
| 10314-1 | MC1568 | LSM-43291 |  | 71433510 | |
| 10315-1 | Rocilinostat | ACY-1215 | LSM-6324 |  | 53340666 |
| 10316-1 | Selisistat | EX-527; SEN196 | LSM-6271 |  | 707029 |
| 10317-1 | AGK2 | LSM-43196 |  | 1183107 | |
| 10318-1 | Resveratrol | LSM-42917 |  | 445154 | |
| 10319-1 | BIX-01294 | LSM-4571 |  | 25150857 | |
| 10320-1 | UNC0638 | LSM-6325 |  | 46224516 |